Letters to the EditorDistance Learning for Educating Anesthesiology ResidentsEditors' ReplyThe β-Blockers Crumbling Continues? A Critical Analysis of the REACH …

…, R Amedee, A Coca, JD DiNicolantonio… - Ochsner …, 2013 - ochsnerjournal.org
We read with interest the winter issue of The Ochsner Journal (Volume 12, Number 4) that
discussed variable aspects about medical education and mentorship. The issue presented …

Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa …

…, G Sardella, F Fedele, JJ DiNicolantonio… - Thrombosis …, 2014 - Elsevier
Aims Limited data are available on prognostic indicators for HIV patients presenting with
ACS. Methods and results Data on consecutive patients with HIV infection receiving standard …

Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting

JJ DiNicolantonio, CJ Beavers, AR Menezes… - The American journal of …, 2014 - Elsevier
A systematic review and meta-analysis was performed to evaluate the effects of carvedilol
versus metoprolol on the incidence of postoperative atrial fibrillation in patients undergoing …

Omega-3 polyunsaturated fatty acids and cardiovascular health: a comprehensive review

…, CJ Lavie, K Marshall, JJ DiNicolantonio… - Progress in …, 2018 - Elsevier
… The ongoing VITAL trial will test the efficacy of Vitamin D (2000 IU/d) and OM3 (1 g/day) for
prevention … Dr Elagizi, Dr DiNicolantonio and Dr Milani report no potential conflicts of interest. …

Sea change for marine omega-3s: randomized trials show fish oil reduces cardiovascular events

EL O'Keefe, WS Harris, JJ DiNicolantonio… - Mayo Clinic …, 2019 - Elsevier
Recently, 3 large randomized controlled trials (RCTs) have assessed the effects of supplementation
with marine omega-3 fatty acids on the occurrence of cardiovascular disease (CVD) …

Clopidogrel, prasugrel, or ticagrelor? A practical guide to use of antiplatelet agents in patients with acute coronary syndromes

NB Norgard, JJ DiNicolantonio - Postgraduate medicine, 2013 - Taylor & Francis
Aspirin is a cornerstone of therapy in the treatment of patients with acute coronary syndromes
(ACS). However, dual antiplatelet therapy reduces the risk of stent thrombosis and …

Ezetimibe plus moderate-dose simvastatin after acute coronary syndrome: what are we IMPROVEing on?

JJ DiNicolantonio, S Chatterjee, CJ Lavie… - The American Journal of …, 2015 - Elsevier
The recent IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT)
is the first study to demonstrate a significant benefit of another medication (ezetimibe) on …

Nutraceutical and dietary resources for breast cancer prevention–Highlighting strategies for suppressing breast aromatase expression

…, LML Luján, MF McCarty, JJ DiNicolantonio - PharmaNutrition, 2023 - Elsevier
Background Visceral obesity and the metabolic syndrome that often accompanies it are robust
and well-established risk factors for postmenopausal breast cancer. This increased risk is …

mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromes

…, JJ DiNicolantonio - Thrombosis and …, 2013 - thieme-connect.com
DiNicolantonio have nothing to declare. Special thanks to Dr. S. … D.Bhatt (CHARISMA) for
the trial data clarification. … Serebruany VL, Atar D. Viewpoint: Central adjudication of myocardial …

[PDF][PDF] Meta-analysis of randomized trials on access site selection for percutaneous coronary intervention in ST-segment elevation myocardial infarction

…, I Ungi, A Thury, T Pintér, JJ Di Nicolantonio… - Archives of Medical …, 2014 - termedia.pl
Results: Twelve RCTs involving 5,124 patients were identified. According to the pooled
analysis, TRPCI was associated with a significant reduction in major bleeding (odds ratio (OR): …